Numerous studies showed that circulating BNP significantly increases in patients with HF, rising in line with New York Heart Association (NYHA) class, and has emerged as a reliable marker for HF and left ventricular dysfunction [12]. This evidence concerns the gene NPPB and hydrops fetalis.